AUROBINDO PHARMA USA., INC, — Capecitabine Importer Profile
Pharmaceutical Importer · #5 buyer for Capecitabine · $866.8K import value · 19 shipments · UNITED STATES · DGFT Verified
AUROBINDO PHARMA USA., INC, is the #5 importer of Capecitabine from India with $866.8K in import value and 19 verified shipments. AUROBINDO PHARMA USA., INC, holds a 0.9% market share in Capecitabine imports based in UNITED STATES. The company sources from 1 verified supplier across 11 formulations shipped to 1 country. Overall, AUROBINDO PHARMA USA., INC, imports 27 pharmaceutical products worth $63.1M across 11 therapeutic categories.
AUROBINDO PHARMA USA., INC, — Capecitabine Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Capecitabine to AUROBINDO PHARMA USA., INC,?
Verified from 19 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| EUGIA PHARMA SPECIALITIES LIMITED | $866.8K | 19 | 100.0% |
AUROBINDO PHARMA USA., INC, sources Capecitabine from 1 verified Indian supplier based on 19 customs records. The primary supplier is EUGIA PHARMA SPECIALITIES LIMITED accounting for 100.0% of imports.
How Does AUROBINDO PHARMA USA., INC, Compare to Nearest Capecitabine Importers?
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $1.1M | 31 | $37.0K |
| 8 | LIFESTAR PHARMA LLC | UNITED STATES | $844.8K | 40 | $21.1K |
| 5 | AUROBINDO PHARMA USA., INC, ★ | UNITED STATES | $800.0K | 16 | $50.0K |
| 11 | TARO PHARMACEUTICALS INC. | CANADA | $578.8K | 13 | $44.5K |
| 2 | ASCEND LABORATORIES LLC | UNITED STATES | $550.0K | 11 | $50.0K |
AUROBINDO PHARMA USA., INC, ranks #5 among 516 Capecitabine importers from India. Average shipment value of $50.0K compared to the market average of $20.0K. The closest competitors by value are AUROLOGISTICS LLC, (AUROBINDO PHARM and LIFESTAR PHARMA LLC.
Where Does AUROBINDO PHARMA USA., INC, Import Capecitabine To?
Destination countries from 19 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $866.8K | 19 | 100.0% |
AUROBINDO PHARMA USA., INC, imports Capecitabine to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $866.8K.
What Capecitabine Formulations Does AUROBINDO PHARMA USA., INC, Import?
| Formulation | Value | Shipments |
|---|---|---|
| CAPECITABINE TABLETS 500MG (CAPECITABINE | $250.0K | 5 |
| CAPECITABINE TABLETS 500MG (CAPECITABINETABLETS USP 500MG 120 S PACK) (QTY: 6173 PACKS) | $136.4K | 3 |
| CAPECITABINE TABLETS 500MG (CAPECITABINETABLETS USP 500MG 120 S PACK) (QTY: 4891 PACKS) | $109.4K | 3 |
| CAPECITABINE TABLETS 500MG (CAPECITABINETABLETS USP 500MG 120 S PACK) (QTY: 7342 PACKS) | $50.0K | 1 |
| CAPECITABINE TABLETS 500MG (CAPECITABINETABLETS USP 500MG 120 S PACK) (QTY: 4865 PACKS) | $50.0K | 1 |
| CAPECITABINE TABLETS 500MG (CAPECITABINETABLETS USP 500MG 120 S PACK) (QTY: 9792 PACKS) | $50.0K | 1 |
| CAPECITABINE TABLETS 500MG (CAPECITABINETABLETS USP 500MG 120 S PACK) (QTY: 7356 PACKS) | $50.0K | 1 |
| CAPECITABINE TABLETS 500MG (CAPECITABINETABLETS USP 500MG 120 S PACK) (QTY: 7333 PACKS) | $50.0K | 1 |
| CAPECITABINE TABLETS 500MG (CAPECITABINETABLETS USP 500MG 120 S PACK) (QTY: 4934 PACKS) | $50.0K | 1 |
| CAPECITABINE TABLETS 500MG (CAPECITABINETABLETS USP 500MG 120 S PACK) (QTY: 2458 PACKS) | $50.0K | 1 |
AUROBINDO PHARMA USA., INC, imports 11 distinct Capecitabine formulations from India. The top formulation is CAPECITABINE TABLETS 500MG (CAPECITABINE with 5 shipments worth $250.0K.
Regulatory Requirements: Importing Capecitabine into United States
What AUROBINDO PHARMA USA., INC, and other importers must comply with to import Capecitabine from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Capecitabine
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Capecitabine from India and How Much Does AUROBINDO PHARMA USA., INC, Import?
India exported $10.3M worth of Capecitabine through 2,246 shipments from 216 suppliers to 123 countries, serving 516 buyers globally. AUROBINDO PHARMA USA., INC, imports $866.8K of this total, accounting for 0.9% of India's Capecitabine exports with 19 shipments from UNITED STATES. This is verified from 19 customs shipment records covering 11 distinct formulations.
What Is the Average Order Value for AUROBINDO PHARMA USA., INC,'s Capecitabine Imports?
AUROBINDO PHARMA USA., INC,'s average Capecitabine order value is $45.6K per consignment, based on 19 shipments totaling $866.8K. AUROBINDO PHARMA USA., INC, is based in UNITED STATES and ranks #5 among all Capecitabine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Capecitabine to AUROBINDO PHARMA USA., INC,?
AUROBINDO PHARMA USA., INC, sources Capecitabine from 1 verified Indian supplier: EUGIA PHARMA SPECIALITIES LIMITED ($866.8K, 100.0%). This is based on 19 customs records.
How Does AUROBINDO PHARMA USA., INC, Compare to Other Capecitabine Importers?
AUROBINDO PHARMA USA., INC, ranks #5 among 516 Capecitabine importers from India with a 0.9% market share. The top 3 importers are NOVADOZ PHARMACEUTICALS LLC ($3.0M), AUROLOGISTICS LLC, (AUROBINDO PHARM ($1.1M), LIFESTAR PHARMA LLC ($844.8K). AUROBINDO PHARMA USA., INC, processed 19 shipments from UNITED STATES.
What Other Advanced Oncology Products Does AUROBINDO PHARMA USA., INC, Import?
AUROBINDO PHARMA USA., INC, also imports these advanced oncology products. Each links to the detailed product page.
About AUROBINDO PHARMA USA., INC,
AUROBINDO PHARMA USA., INC, imports 27 products worth $63.1M. Beyond Capecitabine, top products include Amoxicillin, Potassium, Tamoxifen, Cefuroxime, Lenalidomide. View the complete AUROBINDO PHARMA USA., INC, profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Capecitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Capecitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: AUROBINDO PHARMA USA., INC, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as AUROBINDO PHARMA USA., INC,'s capped import value divided by total capped export value for Capecitabine across all Indian exporters.
- 5.Verified Records: This page is backed by 19 individual customs records matching AUROBINDO PHARMA USA., INC, importing Capecitabine, covering 11 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 516+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Capecitabine Import Data for AUROBINDO PHARMA USA., INC,
Access order-level details, pricing data, supplier connections, and competitive analysis for AUROBINDO PHARMA USA., INC,'s Capecitabine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AUROBINDO PHARMA USA., INC,
Full Company Profile →
27 products · $63.1M total trade · 11 categories
AUROBINDO PHARMA USA., INC, × Capecitabine
Verified from customs records
Company Overview
Top Products by AUROBINDO PHARMA USA., INC,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for AUROBINDO PHARMA USA., INC,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Capecitabine. For current order-level data, contact TransData Nexus.